Development of Graves' disease following radioiodine treatment for autonomously functioning thyroid adenoma: case report.
A patient with development of autoimmune hyperthyroidism following radioiodine treatment for autonomously functioning thyroid adenoma is presented. This is a rare occurrence, probably as a consequence of shedding of the thyroid-stimulating hormone receptor, which is a source of antigen leading to activation of the autoimmune response in susceptible individuals.
University Department of Endocrinology, Diabetes and Metabolism, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Jadranka
J
Martinko
Maja
M
Cigrovski-Berković
Branko
B
Becejac
Darko
D
Solter
Miljenko
M
Solter
D005260:Female; D006111:Graves Disease / Q000209:etiology*; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D013964:Thyroid Neoplasms / Q000532:radiotherapy*
D007457:Iodine Radioisotopes